Pesquisas alternativas:
level rather » levels rather (Expandir a Pesquisa), level rate (Expandir a Pesquisa), level rates (Expandir a Pesquisa)
does novel » does nose (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug de (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
dose life » dose live (Expandir a Pesquisa), whose life (Expandir a Pesquisa), house life (Expandir a Pesquisa)
life ther » life theory (Expandir a Pesquisa), life either (Expandir a Pesquisa), life mother (Expandir a Pesquisa)
level rather » levels rather (Expandir a Pesquisa), level rate (Expandir a Pesquisa), level rates (Expandir a Pesquisa)
does novel » does nose (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug de (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
dose life » dose live (Expandir a Pesquisa), whose life (Expandir a Pesquisa), house life (Expandir a Pesquisa)
life ther » life theory (Expandir a Pesquisa), life either (Expandir a Pesquisa), life mother (Expandir a Pesquisa)
1
Por Rather, Irfan A., Bajpai, Vivek K., Huh, Yun Suk, Han, Young-Kyu, Bhat, Eijaz A., Lim, Jeongheui, Paek, Woon K., Park, Yong-Ha
Publicado no Front Microbiol (2018)
“... by the treatment of a standard drug clobetasol and SEL001. Further, mRNA expression analysis indicated a...”Publicado no Front Microbiol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“...; the clearance considers the decay rate of the drug concentration–time profile, while the half-life considers...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Waalewijn, Hylke, Turkova, Anna, Rakhmanina, Natella, Cressey, Tim R., Penazzato, Martina, Colbers, Angela, Burger, David M.
Publicado no Ther Drug Monit (2019)
“... therapeutic drug monitoring in optimizing the dosing of ARVs in children. METHODS: A PubMed search...”Publicado no Ther Drug Monit (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Wang, Xue Yan, Lim-Jurado, Margaret, Prepageran, Narayanan, Tantilipikorn, Pongsakorn, Wang, De Yun
Publicado no Ther Clin Risk Manag (2016)
“... that it has very low potential for drug–drug interactions, and does not require dose adjustment in renal...”Publicado no Ther Clin Risk Manag (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“... on gd12 than gd8. Each microvascular level responded to each agonist on gd8 and gd12. At gd12...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“.... The half-life of the two drugs in these monkeys was determined to be between 3 and 4 h, and drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Pertwee, Roger G.
Publicado em 2005
“...(1) and/or CB(2) receptor agonist or antagonist that does or does not readily cross the blood brain...”Publicado em 2005
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“...Identification of novel molecular targets is critical in development of new and efficient cancer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“... include directly observed therapy and peer-based models. A high level of acceptance of the individual life...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Handley, Simon A., Bowskill, Sally V.J., Patel, Maxine X., Flanagan, Robert J.
Publicado em 2013
“.... This is probably because of the short plasma half-life of the drug, at least in part. Nevertheless, quetiapine TDM...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Supp, Gernot G., Higgen, Focko L., Hipp, Joerg F., Engel, Andreas K., Siegel, Markus
Publicado no Front Pharmacol (2018)
“... AEPs during remifentanil medication. This decrease was predicted by drug dose, rather than sedation...”Publicado no Front Pharmacol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Canal, Clinton E., Morgan, Drake, Felsing, Daniel, Kondabolu, Krishnakanth, Rowland, Neil E., Robertson, Kimberly L., Sakhuja, Rajeev, Booth, Raymond G.
Publicado em 2014
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Klymenko, Tetyana, Brandenburg, Martin, Morrow, Christopher, Dive, Caroline, Makin, Guy
Publicado em 2011
“..., and leads to pleiotropic drug resistance, mediated by Bcl-2 family proteins. ABT-737 is a novel small...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por King, Cynthia A., Babcock, Kathleen M., Godios, Rhianna J., King, Benjamin S.
Publicado no Ther Adv Drug Saf (2018)
“... that nafcillin causes CYP3A4 enzyme induction which decreases warfarin’s half-life. The onset of CYP3A4 induction...”Publicado no Ther Adv Drug Saf (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Schlesinger, Naomi, De Meulemeester, Marc, Pikhlak, Andrey, Yücel, A Eftal, Richard, Dominik, Murphy, Valda, Arulmani, Udayasankar, Sallstig, Peter, So, Alexander
Publicado em 2011
“...-steroidal anti-inflammatory drugs and/or colchicine were randomized to receive a single subcutaneous dose...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
“..., weight, serum creatinine, dose/interval, serum drug peaks and troughs, results of discharge hearing test...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
“... of efficacy can maximize the utility of these life-saving drugs. Unfortunately, clinical data remains limited...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por César-Razquin, Adrián, Girardi, Enrico, Yang, Mi, Brehme, Marc, Saez-Rodriguez, Julio, Superti-Furga, Giulio
Publicado no Front Pharmacol (2018)
“...The interplay between drugs and cell metabolism is a key factor in determining both compound...”Publicado no Front Pharmacol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Qi, Haiyan, Su, Feng‐Yun, Wan, Shan, Chen, Yongjie, Cheng, Yan‐Qiong, Liu, Ai‐Jun
Publicado no CNS Neurosci Ther (2014)
“...BACKGROUND AND PURPOSE: The immunosuppressant drug rapamycin was reported to have an antiaging...”Publicado no CNS Neurosci Ther (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Seeger, J M, Brinkmann, K, Yazdanpanah, B, Haubert, D, Pongratz, C, Coutelle, O, Krönke, M, Kashkar, H
Publicado em 2010
“... in different tumour entities. However, rather than being an adverse prognostic marker, recent data suggest...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo